EUVIMEDEUVIMED entdecken
Open Access

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models

Carolin M Lieber iD, Josef D Wolf iD, Mugunthan Govindarajan, Jeong-Joong Yoon iD, Zachary M Sticher iD, Claire E Ruckel iD, Alexander I Leach iD, Lauren A Harrison iD, Dariia Vyshenska iD, Amalia A Cruz iD, Meghan K Andrews iD, Rebecca E Krueger iD und 5 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aef1594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Carolin M Lieber und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Measles virus, Antiviral Agents, Measles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthoparamyxoviruses, such as human parainfluenza virus type 3 (HPIV3) and measles virus (MeV), are a major health threat. We discovered an orally efficacious broad-spectrum inhibitor of orthoparamyxovirus polymerases. However, here, we found that tolerability in higher mammals was limited. We report the development of the clinical candidate analog GHP-88310 (EIDD-3608), which combines improved oral efficacy with favorable tolerability in nonrodents (ferrets and dogs). GHP-88310 was active against HPIV3, Sendai virus (SeV), MeV, and related canine distemper virus (CDV). In 7-day tolerability studies, daily doses of 2000 mg/kg were well tolerated. Pharmacokinetic analysis revealed altered plasma exposure of GHP-88310 compared to the original hit. In HPIV3-infected cotton rats, GHP-88310 lowered the respiratory tract viral load. Dosing of ferrets infected with CDV, causing lethal measles-like disease, resulted in complete survival, reduction of viremia and shed viral load, and alleviated lymphocytopenia. Once-daily GHP-88310 was efficacious in the CDV-ferret and HPIV3-cotton rat models. The compound was sterilizing against HPIV3 at physiological concentrations in human airway epithelium organoids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Measles virusAntiviral AgentsMeaslesAnimalsDogsAdministration, OralHumansFerretsDisease Models, AnimalSendai virusParainfluenza Virus 3, HumanViral LoadDistemper Virus, CanineSigmodontinaeFemaleRecombinant Fusion Proteins

Substanzen

Antiviral AgentsoplunofuspRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, GA 30303, USA.
  • Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.
  • Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA 98195, USA.

ORCID-Profile: Carolin M Lieber, Josef D Wolf, Jeong-Joong Yoon, Zachary M Sticher, Claire E Ruckel, Alexander I Leach, Lauren A Harrison, Dariia Vyshenska, Amalia A Cruz, Meghan K Andrews, Rebecca E Krueger, George R Painter, Alexander L Greninger, Richard K Plemper

Förderung

  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Lieber, C. M., Wolf, J. D., Govindarajan, M., Yoon, J. J., Sticher, Z. M., Ruckel, C. E., Leach, A. I., Harrison, L. A., Vyshenska, D., Cruz, A. A., Andrews, M. K., Krueger, R. E., Cox, R. M., Painter, G. R., Greninger, A. L., Natchus, M. G., & Plemper, R. K. (2026). Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models. Science Advances. https://doi.org/10.1126/sciadv.aef1594

Vancouver

Lieber CM, Wolf JD, Govindarajan M, Yoon JJ, Sticher ZM, Ruckel CE, et al. Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models. Science Advances. 2026. doi:10.1126/sciadv.aef1594

BibTeX
@article{Lieber2026,
  author = {Lieber, Carolin M and Wolf, Josef D and Govindarajan, Mugunthan and Yoon, Jeong-Joong and Sticher, Zachary M and Ruckel, Claire E and Leach, Alexander I and Harrison, Lauren A and Vyshenska, Dariia and Cruz, Amalia A and Andrews, Meghan K and Krueger, Rebecca E and Cox, Robert M and Painter, George R and Greninger, Alexander L and Natchus, Michael G and Plemper, Richard K},
  title = {Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aef1594}
}
Kostenlos starten →